Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Defined Observation Result	NCIT_C93417	[A reusable, "template" description of a possible outcome of an observation.]
Defined Stratification Criterion Permissible Result	NCIT_C93418	[A reusable, "template" description of an allowable response to a stratification criterion.]
Fructose	NCIT_C68480
Performed Clinical Result	NCIT_C93419	[A result of a clinical observation, i.e. from an examination, test or direct observation performed on the subject.]
Fucose	NCIT_C68481
AKT3 Gene Amplification	NCIT_C132895	[A molecular genetic abnormality indicating the presence of multiple copies of the AKT3 gene.]
PIK3C2B Gene Amplification	NCIT_C132896	[A molecular genetic abnormality indicating the presence of multiple copies of the PIK3C2B gene.]
PIK3C2B Gene	NCIT_C102942	[This gene is involved in the metabolism of phosphoinositol.]
CDK6 Gene Amplification	NCIT_C132897	[A molecular genetic abnormality indicating the presence of multiple copies of the CDK6 gene.]
CDK6 Gene	NCIT_C97384	[This gene plays a role in the progression of the cell cycle.]
Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8	NCIT_C132898	[Stage I includes: (T0, N0, M0); (T0, N1, M0); (T1, N0, M0); (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Tumor with metastasis in four or fewer lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)]
Hepatocyte Growth Factor	NCIT_C20428	[Hepatocyte growth factor (728 aa, ~83 kDa) is encoded by the human HGF gene. This protein is involved in both the modulation of hepatocyte proliferation and growth factor receptor signaling in hepatocytes and many other cell types.]
Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8	NCIT_C132899	[Stage II includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4: Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. N0: No regional lymph node metastasis. N1: Tumor with metastasis in four or fewer lymph nodes. N2: Tumor with metastasis in more than four lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)]
Erythropoietin	NCIT_C20429	[Erythropoietin (193 aa, ~21 kDa) is encoded by the human EPO gene. This protein plays a role in both erythropoiesis and the maintenance of red blood cell volume.]
Epidermal Growth Factor	NCIT_C20425	[Epidermal growth factor (53 aa, ~6 kDa) is encoded by the human EGF gene. This protein is involved in mitogenesis and magnesium reabsorption.]
EGF Gene Product	NCIT_C118402	[A protein encoded by the EGF gene.]
Hematopoietic and Lymphoid Cell	NCIT_C32725	[One of the cells of the blood or bone marrow, a leukocyte or erythrocyte.]
Immune System	NCIT_C12735	[The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component.]
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8	NCIT_C132891	[Stage III includes: (T0, N3, M0); (T1, N3, M0); (T2, N3, M0); (T3, N3, M0); (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (T4, N3, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or more ipsilateral lymph nodes, none larger than 6 cm. N2: Tumor with contralateral or bilateral lymph nodes metastasis, none larger than 6 cm. N3: Tumor with lymph node(s) metastasis, larger than 6 cm. M0: No distant metastasis. (AJCC 8th ed.)]
HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage	NCIT_C132883	[A term that refers to the clinical staging of HPV-mediated (p16-positive) oropharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition.]